Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 73

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 73
---
 approve, recommend or enter into a binding written agreement with 
 respect to a Superior Proposal subject, in each case, to compliance with Section 6.2 and Section 8.3(a); |

| (B) | Breach of Representation or Warranty or Failure to Perform Covenant by the Purchaser. A breach of any                                                                                                                                    
 representation or warranty or failure to perform any covenant or agreement on the part of the Purchaser under this Agreement occurs that would cause any condition in 7.3(a) [Representations and Warranties of the Purchaser] or 7.3(b) 
 [Performance of Covenants by the Purchaser] not to be satisfied, and such breach or failure is incapable of being cured or is not cured in accordance with the terms of 5.7(c); provided that the Company is not then in breach of this  
 Agreement so as to directly or indirectly cause any condition in 7.2(a) [Representations and Warranties of the Company] or 7.2(b) [Performance of Covenants by the Company] not to be satisfied;                                         |

| (iii) | by the Purchaser: |

| (A) | Breach of Representation or Warranty or Failure to Perform Covenant by the Company. A breach of any                                                                                                                                  
 representation or warranty or failure to perform any covenant or agreement on the part of the Company under this Agreement occurs that would cause any condition in 7.2(a) [Representations and Warranties of the Company] or 7.2(b) 
 [Performance of Covenants by the Company] not to be satisfied, and such breach or failure is incapable of being cured or is not cured in accordance with the terms of 5.7(c); provided that the Purchaser is not then in breach of   
 this Agreement so as to directly or indirectly cause any condition in 7.3(a) [Representations and Warranties of the Purchaser] or 7.3(b) [Performance of Covenants by the Purchaser] not to be satisfied; and                        |

| (B) | Change in Recommendation or Superior Proposal. If the Board of Directors or the Transaction Committee                                                                                                                                                    
 (1)(I) withholds or withdraws (or amends, modifies or qualifies in a manner adverse to Parent or the Purchaser) the Board Recommendation, or proposes publicly to withhold or withdraw (or amend, modify or qualify in a manner adverse to Parent or the 
 Purchaser) the Board Recommendation or fails